Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.52% |
| 2 | Technology | 7.24% |
| 3 | Financials | 6.69% |
| 4 | Healthcare | 6.46% |
| 5 | Industrials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CALL
United Therapeutics
UTHR
$22.1B
| $4.49M | ﹤0.01% |
+25,000
| New | +$4.76M |
|
|
PSPC
3002
DELISTED
Post Holdings Partnering Corporation
PSPC
| $4.49M | ﹤0.01% |
458,598
+17,228
| +4% | +$168K |
|
|
LNW
3003
DELISTED
Light & Wonder
LNW
| $4.48M | ﹤0.01% |
76,320
-137,767
| -64% | -$8.33M |
|
3004
PUT
Arcus Biosciences
RCUS
$3.72B
| $4.48M | ﹤0.01% |
+141,900
| New | +$4.75M |
|
|
SKE
3005
Skeena Resources
SKE
$4.17B
| $4.48M | ﹤0.01% |
401,732
+346,369
| +626% | +$3.9M |
|
|
BLUE
3006
DELISTED
bluebird bio
BLUE
| $4.47M | ﹤0.01% |
46,137
+19,578
| +74% | +$2.58M |
|
|
CBD
3007
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $4.47M | ﹤0.01% |
887,907
+635,402
| +252% | +$2.7M |
|
3008
Tevogen Inc
TVGN
$44.9M
| $4.47M | ﹤0.01% |
+8,958
| New | +$4.45M |
|
3009
Corvus Pharmaceuticals
CRVS
$1.19B
| $4.47M | ﹤0.01% |
2,723,539
-196,520
| -7% | -$360K |
|
3010
The Joint Corp
JYNT
$119M
| $4.46M | ﹤0.01% |
125,870
+30,240
| +32% | +$1.4M |
|
|
DLCA
3011
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
| $4.46M | ﹤0.01% |
454,103
+6,848
| +2% | +$66.9K |
|
3012
Afya
AFYA
$1.29B
| $4.44M | ﹤0.01% |
308,379
+230,066
| +294% | +$3.15M |
|
3013
Truist Financial
TFC
$61.6B
| $4.44M | ﹤0.01% |
78,331
-539,984
| -87% | -$33.4M |
|
3014
Raymond James Financial
RJF
$34.5B
| $4.44M | ﹤0.01% |
40,371
-511,008
| -93% | -$54.1M |
|
3015
Zurn Elkay Water Solutions
ZWS
$7.97B
| $4.43M | ﹤0.01% |
125,284
+106,280
| +559% | +$3.53M |
|
3016
Sixth Street Specialty
TSLX
$1.79B
| $4.43M | ﹤0.01% |
+190,375
| New | +$4.46M |
|
|
TMAC
3017
DELISTED
The Music Acquisition Corporation
TMAC
| $4.43M | ﹤0.01% |
454,617
-12,220
| -3% | -$119K |
|
3018
First Advantage
FA
$3.61B
| $4.43M | ﹤0.01% |
219,461
+130,615
| +147% | +$2.25M |
|
3019
Q2 Holdings
QTWO
$4.06B
| $4.43M | ﹤0.01% |
71,876
+42,807
| +147% | +$2.74M |
|
3020
Enovix
ENVX
$737M
| $4.42M | ﹤0.01% |
353,969
+128,239
| +57% | +$1.8M |
|
|
ANAC
3021
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $4.42M | ﹤0.01% |
450,992
+47,445
| +12% | +$462K |
|
|
GMS
3022
DELISTED
GMS Inc
GMS
| $4.41M | ﹤0.01% |
88,661
+4,843
| +6% | +$255K |
|
3023
Forrester Research
FORR
$236M
| $4.39M | ﹤0.01% |
77,890
+17,305
| +29% | +$933K |
|
3024
PUT
Hasbro
HAS
$13.3B
| $4.38M | ﹤0.01% |
53,500
| – | – |
|
3025
Maximus
MMS
$3.13B
| $4.38M | ﹤0.01% |
58,381
-361,308
| -86% | -$27.6M |
|
Similar funds
Israel Englander's Q1 2022 Portfolio in Review
As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Israel Englander's Q1 2022 filing shows 1,491 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 58% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Israel Englander opened 1,491 new positions and closed 1,365 in Q1 2022.
- Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.